Skip to main content

Peer Review reports

From: Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer

Original Submission
28 Jan 2011 Submitted Original manuscript
23 Mar 2011 Reviewed Reviewer Report - RONG-GUANG SHAO
16 Jun 2011 Author responded Author comments - Lin Guo
Resubmission - Version 2
16 Jun 2011 Submitted Manuscript version 2
23 Jun 2011 Author responded Author comments - Lin Guo
Resubmission - Version 3
23 Jun 2011 Submitted Manuscript version 3
Publishing
25 Jun 2011 Editorially accepted
25 Jun 2011 Article published 10.1186/1471-2407-11-270

You can find further information about peer review here.

Back to article page